Receptor-binding domain as a target for developing SARS vaccines.
about
Receptor-binding domain-based subunit vaccines against MERS-CoVCurrent advancements and potential strategies in the development of MERS-CoV vaccinesTailoring subunit vaccine immunity with adjuvant combinations and delivery routes using the Middle East respiratory coronavirus (MERS-CoV) receptor-binding domain as an antigen.Receptor binding domain based HIV vaccines.Recombinant Receptor Binding Domain Protein Induces Partial Protective Immunity in Rhesus Macaques Against Middle East Respiratory Syndrome Coronavirus Challenge.Coronaviruses: important emerging human pathogens.Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice.
P2860
Q26851979-5ED88EE6-A3ED-4282-8128-7AD3D0664B82Q27012578-3330C6EB-3165-4170-9A1F-E810E5EC1CCAQ30368736-BD46B4B9-87D3-4162-8A8A-E4CA7183671CQ35033862-94B483A7-EACF-4E64-AEFB-73E3BEAF27D1Q36252666-A7A7306C-DE3A-4103-8FE0-8E5FA36E8325Q38193770-2D27FEAE-5E82-4F3E-BB85-7702C2580CD7Q40744757-82D4DF37-319D-41E0-8469-195AB5C72871
P2860
Receptor-binding domain as a target for developing SARS vaccines.
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Receptor-binding domain as a target for developing SARS vaccines.
@ast
Receptor-binding domain as a target for developing SARS vaccines.
@en
type
label
Receptor-binding domain as a target for developing SARS vaccines.
@ast
Receptor-binding domain as a target for developing SARS vaccines.
@en
prefLabel
Receptor-binding domain as a target for developing SARS vaccines.
@ast
Receptor-binding domain as a target for developing SARS vaccines.
@en
P2860
P50
P1476
Receptor-binding domain as a target for developing SARS vaccines.
@en
P2093
P2860
P304
P356
10.3978/J.ISSN.2072-1439.2013.06.06
P478
P577
2013-08-01T00:00:00Z